1. In Vivo

Has the Real MIS Revolution Finally Arrived?

Robotics, or computer-enhanced surgery, still has its skeptics. But a small group of start-up device companies are pushing forward, claiming that they represent a radically new--and better--way to do surgery. The dilemma for the small companies: to sell the concept behind robotics while, at the same time, competitively positioning their individual offerings.

by David Cassak

Real revolutions happen in stages. The French Revolution, after all, produced first despotism (Napoleon), then a constitutional monarchy (Louis XVIII) before real democracy was established nearly 100 years later. Would...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from In Vivo

How Vir Bio CEO Marianne De Backer Is Rebuilding Commercial Momentum

 
• By David Wild

From billion-dollar COVID antibody to a strategic reset, Marianne De Backer is navigating Vir's comeback through pipeline focus and disciplined leadership.

Execs On The Move: April 2025

 
• By In Vivo Team

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

AI In Drug Discovery: The Patent Implications

 
• By David Wild

A Q&A with DeAnn Smith, partner and co-chair of the Patent Trial and Appeal Board Proceedings Practice Group at law firm Foley Hoag.